VIA
USNA icon

Vident Investment Advisory’s Usana Health Sciences USNA Stock Holding History

Vident Investment Advisory’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,365
Closed -$525K – 1343
2022
Q3 		$525K Buy
9,365
+295
+3% +$19.5K 0.02% 775
2022
Q2 		$656K Buy
9,070
+592
+7% +$44.1K 0.02% 772
2022
Q1 		$674K Buy
8,478
+788
+10% +$71K 0.02% 832
2021
Q4 		$779K Buy
7,690
+225
+3% +$22.4K 0.02% 793
2021
Q3 		$687K Sell
7,465
-1,240
-14% -$119K 0.02% 790
2021
Q2 		$892K Sell
8,705
-267
-3% -$26.8K 0.03% 684
2021
Q1 		$876K Sell
8,972
-9,073
-50% -$826K 0.03% 647
2020
Q4 		$1.39M Sell
18,045
-1,051
-6% -$81.3K 0.06% 440
2020
Q3 		$1.41M Buy
19,096
+2,598
+16% +$208K 0.07% 392
2020
Q2 		$1.21M Sell
16,498
-2,660
-14% -$209K 0.06% 418
2020
Q1 		$1.11M Buy
19,158
+4,347
+29% +$302K 0.07% 362
2019
Q4 		$1.16M Buy
+14,811
New +$1.09M 0.07% 381
2019
Q2 		– Sell
-16,877
Closed -$1.42M – 646
2019
Q1 		$1.42M Sell
16,877
-4,422
-21% -$462K 0.08% 357
2018
Q4 		$2.51M Sell
21,299
-2,983
-12% -$345K 0.14% 167
2018
Q3 		$2.93M Buy
+24,282
New +$3.01M 0.11% 246
2015
Q4 		– Sell
-13,790
Closed -$924K – 825
2015
Q3 		$924K Sell
13,790
-102
-0.7% -$7.21K 0.13% 213
2015
Q2 		$949K Buy
13,892
+674
+5% +$42.8K 0.13% 214
2015
Q1 		$734K Sell
13,218
-3,804
-22% -$195K 0.15% 189
2014
Q4 		$873K Buy
+17,022
New +$836K 0.29% 65

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vident Investment Advisory's USNA Position: Q4 2022 in Review

Vident Investment Advisory sold out of Usana Health Sciences (USNA) in Q4 2022, closing a stake of 9,365 shares — an estimated $525K sold.

Vident Investment Advisory first reported a position in USNA in Q4 2014 and held it in 19 quarters. The position peaked at $2.93M in Q3 2018. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2022.

  • Vident Investment Advisory reported no remaining Usana Health Sciences position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 9,365 Usana Health Sciences shares in Q4 2022, an estimated $525K.
  • Vident Investment Advisory first reported a position in Usana Health Sciences in Q4 2014 and held it in 19 quarters.
  • Vident Investment Advisory's Usana Health Sciences position peaked at $2.93M in Q3 2018.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.